Although we have found that GZMK plays an important role in breast cancer and has significant value in predicting breast cancer prognosis, it holds promise as a target for breast cancer immunotherapy or as a biomarker for predicting immunotherapy efficacy. This evidence concerns the gene GZMK and breast cancer.